Skip to main navigation Skip to search Skip to main content

Liraglutide Effect and Action in Diabetes (LEAD-3): Effect of Glycemic Control of Two Doses of Liraglutide vs Glimepiride in Type 2 Diabetes (A 52-Week (with 52 Week Open Label Extension), Double-blind, Multicenter, Randomized, Parallel Stu

  • Weinstock, Ruth (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date03/21/06 → 03/31/11

Funding

  • Novo Nordisk Pharmaceuticals Incorporated: $77,684.80